Innate Pharma Tangible Net Worth Ratio
Innate Pharma tangible net worth ratio. Innate Pharma (IPH) has a Tangible Net Worth Ratio of 100.0% as of June 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€5.14 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of Innate Pharma to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Innate Pharma (2003–2024)
Tangible net worth ratio of Innate Pharma from 2003 to 2024. This chart shows how Innate Pharma's Tangible Net Worth Ratio has changed across 22 annual periods from 2003 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting net assets of €5.14 Million with intangible assets of €0.00 EUR. See Innate Pharma short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Innate Pharma Tangible Net Worth Ratio by Year (2003–2024)
Innate Pharma tangible net worth ratio by year from 2003 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Innate Pharma from 2003 to 2024, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is Innate Pharma worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | €8.83 Million | €0.00 | €111.06 Million | ▲ +0.8 pp |
| 2023 | 99.2% | €51.90 Million | €416.00K | €184.19 Million | ▲ +77.8 pp |
| 2022 | 21.4% | €54.15 Million | €42.55 Million | €207.86 Million | ▼ -37.5 pp |
| 2021 | 58.9% | €107.44 Million | €44.19 Million | €267.50 Million | ▼ -11.5 pp |
| 2020 | 70.3% | €155.97 Million | €46.29 Million | €307.42 Million | ▲ +14.9 pp |
| 2019 | 55.4% | €217.42 Million | €96.97 Million | €401.36 Million | ▲ +5.9 pp |
| 2018 | 49.5% | €167.24 Million | €84.53 Million | €451.22 Million | ▲ +3.2 pp |
| 2017 | 46.3% | €85.96 Million | €46.19 Million | €255.02 Million | ▼ -43.2 pp |
| 2016 | 89.5% | €86.17 Million | €9.07 Million | €281.58 Million | ▲ +3.0 pp |
| 2015 | 86.5% | €72.07 Million | €9.73 Million | €305.96 Million | ▼ -6.3 pp |
| 2014 | 92.8% | €74.63 Million | €5.36 Million | €90.69 Million | ▼ -7.2 pp |
| 2013 | 100.0% | €40.29 Million | €0.00 | €55.88 Million | ▲ +0.0 pp |
| 2012 | 100.0% | €23.36 Million | €0.00 | €48.30 Million | ▲ +0.0 pp |
| 2011 | 100.0% | €26.62 Million | €0.00 | €60.11 Million | ▲ +0.0 pp |
| 2010 | 100.0% | €33.52 Million | €0.00 | €48.01 Million | ▲ +0.0 pp |
| 2009 | 100.0% | €47.12 Million | €0.00 | €64.22 Million | ▲ +0.0 pp |
| 2008 | 100.0% | €41.34 Million | €0.00 | €60.86 Million | ▲ +0.0 pp |
| 2007 | 100.0% | €49.61 Million | €0.00 | €63.15 Million | ▲ +0.0 pp |
| 2006 | 100.0% | €56.37 Million | €0.00 | €69.25 Million | ▲ +0.2 pp |
| 2005 | 99.8% | €20.07 Million | €34.00K | €24.77 Million | ▲ +1.4 pp |
| 2004 | 98.4% | €25.01 Million | €392.00K | €29.51 Million | ▲ +0.8 pp |
| 2003 | 97.6% | €15.11 Million | €361.00K | €20.38 Million | — |